Live Breaking News & Updates on Following Upcoming

Stay updated with breaking news from Following upcoming. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Poxel Reports Financial Results for First Half 2023 and Provides a Corporate Update

LYON, France, September 26, 2023 Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced its financial results for the period ended June 30, 2023 and provided a corporate update. ....

France General , New York , United States , Khoso Baluch , Merck Serono , Sumitomo Pharma , Manavarere Arthur Rouill , Thomas Kuhn , Sophie Bozec , Nicolas Fossiez , Financial Press , European Patent Office , Community Weekend , International Meeting , Alex Leukodystrophy Charity , Meeting Of The Japanese Diabetes Society , United Leukodystrophy Foundation Scientific Symposium , Company Universal Registration Document , Us Patent Office , Regulatory News , Chief Executive Officer , Imeglimin Phase , Annual Meeting , Japanese Diabetes Society , Long Term Study , Japanese Type ,